Skip to main content

The CTD² Network and Cancer Systems Biology Consortium organized a virtual symposium series titled “Multidisciplinary Approaches to Understand Cancer Treatment Resistance”. Please join us on 11/16, 11/17, 12/2, 12/16, and 12/17. Click here to view the registration website.

Publications

644 Publications Available
Nucleic Acids Research

This manuscript presents a method called Evaluation of Dependency DifferentialitY (EDDY), which is a statistical test for differential dependencies of a set of genes between two conditions.

Comb Chem High Throughput Screen

Researchers at Emory disucss their high throughput research platforms and efforts to advance understanding of disease-related biology with its HTS/HCS platforms and chemical tools, in support of  drug discovery.

Cancer Discovery

Investigators used a novel mouse model to study genetic changes in prostate cancer.

Nature Medicine

Researchers identify ARID1A-mutant cancer cells are dependent on ARID1B for survival, suggesting a potential therapeutic target.

Cold Spring Harbor Perspective in Medicine

Researchers screen for synthetic lethal interactions with MYC to identify possible routes for therapy.

Nature Reviews Clinical Oncology

A review of how a systems biology approach to cancer research can effect therapy development.

Cell Reports

The authors performed an image-based screen for genes regulating glioblastoma tumor-initiating cell maintenance and identified the transcription factor, ZFHX4, as a master regulator.

Proceedings of the National Academy of Sciences

The researchers identified the GRB2-associated binding protein 2 (GAB2) as a recurrently amplified gene that potently transforms immortalized ovarian and fallopian tube secretory epithelial cells. 

Cell

Glutathione peroxidase 4 regulates ferroptotic cancer cell death.

Clinical Cancer Research

Investigators identified molecular players in response and resistance to combination chemotherapy and antiangiogenic drugs.